← Open Payments lookup

MINCI MOODY: Open Payments

NPI 1083378343 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,586 in 52 payments from 13 companies in 2025. Trend: 2023 $922 · 2024 $634 · 2025 $1,586

Food & beverage: $1,586
CompanyPaymentsAmount
ABBVIE INC.17$674
Axsome Therapeutics, Inc.12$355
E.R. Squibb & Sons, L.L.C.9$197
Teva Pharmaceuticals USA, Inc.2$60
Neurocrine BioSciences, Inc.2$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$56
Supernus Pharmaceuticals, Inc.2$45
ViiV Healthcare Company1$28
Lundbeck LLC1$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24

Products named: VRAYLAR, Auvelity, COBENFY, UZEDY, INGREZZA, CAPLYTA, Qelbree, DOVATO.

Industry payments across CA — which companies pay providers there.